These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8258325)

  • 1. Increased number of cytotoxic T cells within CD4+8- T cells in beta 2-microglobulin, major histocompatibility complex class I-deficient mice.
    Marusić-Galesić S; Udaka K; Walden P
    Eur J Immunol; 1993 Dec; 23(12):3115-9. PubMed ID: 8258325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
    Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
    J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
    Dalloul AH; Ngo K; Fung-Leung WP
    Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone.
    McAdam AJ; Blieden TM; Frelinger JG; Lord EM
    Eur J Immunol; 1992 Sep; 22(9):2461-4. PubMed ID: 1516633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
    Udaka K; Marusić-Galesić S; Walden P
    J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
    Lamousé-Smith E; McCarthy SA
    Cell Immunol; 1997 Aug; 179(2):107-15. PubMed ID: 9268494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
    Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
    Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination.
    Pullen LC; Miller SD; Dal Canto MC; Kim BS
    Eur J Immunol; 1993 Sep; 23(9):2287-93. PubMed ID: 8370406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD4 can confer major histocompatibility complex class II-associated superantigen reactivity upon a T cell receptor derived from a CD8-dependent cytotoxic T lymphocyte clone.
    Wallace VA; Ohashi PS; Hengartner H; Mak TW
    Eur J Immunol; 1990 Nov; 20(11):2471-7. PubMed ID: 2123792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cells from major histocompatibility complex class II-deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reaction.
    Shimizu T; Takeda S
    Eur J Immunol; 1997 Feb; 27(2):500-8. PubMed ID: 9045923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection.
    Ladel CH; Flesch IE; Arnoldi J; Kaufmann SH
    J Immunol; 1994 Oct; 153(7):3116-22. PubMed ID: 7726898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased number of CD4-CD8+ MHC class II-specific T cells in MHC class II-deficient mice.
    Marusić-Galesić S; Walden P
    Immunology; 1995 Jul; 85(3):442-6. PubMed ID: 7558133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of intraepithelial lymphocytes from major histocompatibility complex (MHC)-deficient mice: no evidence for a role of MHC class II antigens in the positive selection of V delta 4+ gamma delta T cells.
    Schleussner C; Ceredig R
    Eur J Immunol; 1993 Jul; 23(7):1615-22. PubMed ID: 8391987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection.
    Tarleton RL; Koller BH; Latour A; Postan M
    Nature; 1992 Mar; 356(6367):338-40. PubMed ID: 1549177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.
    Hou S; Doherty PC; Zijlstra M; Jaenisch R; Katz JM
    J Immunol; 1992 Aug; 149(4):1319-25. PubMed ID: 1354233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T/B cell interaction involved in induction of the mouse IgG2ab suppression is restricted by major histocompatibility complex class I, but not class II molecules.
    Majlessi L; Bordenave G
    Eur J Immunol; 1997 Jun; 27(6):1346-52. PubMed ID: 9209483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.
    Jhaver KG; Rao TD; Frey AB; Vukmanović S
    J Immunol; 1995 Jun; 154(12):6252-61. PubMed ID: 7759863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.